4081 - 4090 of 8673 Results
Title
Year
-
OPENTitle: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utilityJournal Name: Seizure: European Journal of EpilepsyPublisher: Elsevier BVVol: 101Issue #:Start Page: 156End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003Best OA location URL: http://www.seizure-journal.com/article/S1059131122001820/pdfCitation Count: 7
-
OPENTitle: Long-term adherence of human brain cells in vitro is enhanced by charged amine-based plasma polymer coatingsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 17Issue #: 3Start Page: 489End Page: 506Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2022.01.013Best OA location URL: http://www.cell.com/article/S2213671122000571/pdfCitation Count: 15
-
OPENTitle: Symptom Severity Mixity in Older-Age Bipolar Disorder: Analyses From the Global Aging and Geriatric Experiments in Bipolar Disorder Database (GAGE-BD)Journal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 30Issue #: 10Start Page: 1096End Page: 1107Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jagp.2022.03.007Best OA location URL: https://escholarship.org/uc/item/38k068zmCitation Count: 17
-
OPENTitle: Llamanade: An open-source computational pipeline for robust nanobody humanizationJournal Name: StructurePublisher: Elsevier BVVol: 30Issue #: 3Start Page: 418End Page: 429.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.str.2021.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11698024Citation Count: 32
-
OPENTitle: Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editingJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 62Issue #:Start Page: 102806End Page: 102806Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2022.102806Best OA location URL: https://doi.org/10.1016/j.scr.2022.102806Citation Count: 13
-
OPENTitle: Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation AnalysesJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 30Issue #: 6Start Page: 664End Page: 674Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.11.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9106826Citation Count: 14
-
OPENTitle: Artificial intelligence for detection of Alzheimer's disease: demonstration of real-world value is required to bridge the translational gapJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 4Issue #: 11Start Page: e768End Page: e769Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s2589-7500(22)00190-xBest OA location URL: http://www.thelancet.com/article/S258975002200190X/pdfCitation Count: 2
-
RESTRICTEDTitle: Inconsistency and incongruence: the two diagnostic pillars of functional movement disorderJournal Name: The LancetPublisher: Elsevier BVVol: 400Issue #: 10348Start Page: 328End Page: 328Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(22)01184-9Citation Count: 7
-
RESTRICTEDTitle: Movement disorders research in 2021: cracking the paradigmJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0Citation Count: 18
-
RESTRICTEDTitle: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1099End Page: 1109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8Citation Count: 122